$ENFN
Enfusion, Inc.

2023 Q4 Form 10-K Financial Statement

#000155837024002987 Filed on March 12, 2024

View on sec.gov

Income Statement

Concept 2023 Q4 2023 2021
Revenue $46.49M $174.5M $111.7M
YoY Change 14.73% 16.09% 40.39%
Cost Of Revenue $15.62M $57.64M $31.85M
YoY Change 17.51% 22.38% 49.1%
Gross Profit $30.86M $116.9M $79.86M
YoY Change 13.38% 13.22% 37.19%
Gross Profit Margin 66.39% 66.97% 71.49%
Selling, General & Admin $22.67M $85.05M $202.3M
YoY Change 7.56% -13.26% 341.64%
% of Gross Profit 73.45% 72.76% 253.38%
Research & Development $6.061M $19.89M $153.4M
YoY Change 26.93% 15.91% 2327.98%
% of Gross Profit 19.64% 17.02% 192.1%
Depreciation & Amortization $3.515M $9.987M $3.975M
YoY Change 107.99% 57.42% 73.51%
% of Gross Profit 11.39% 8.54% 4.98%
Operating Expenses $28.73M $104.9M $355.7M
YoY Change 11.14% -8.91% 582.37%
Operating Profit $2.134M $11.95M -$275.9M
YoY Change 55.54% -199.87% -4642.05%
Interest Expense $1.641M $1.641M $4.594M
YoY Change 287.03% 297.34% 176.41%
% of Operating Profit 76.9% 13.73%
Other Income/Expense, Net -$1.673M -$464.0K -$5.779M
YoY Change 183.56% 106.22% 265.76%
Pretax Income $2.180M $11.48M -$281.7M
YoY Change 80.76% -194.22% -6367.53%
Income Tax $1.280M $2.231M $579.0K
% Of Pretax Income 58.72% 19.43%
Net Earnings $638.0K $6.025M -$158.3M
YoY Change 46.0% -178.72% -3998.47%
Net Earnings / Revenue 1.37% 3.45% -141.73%
Basic Earnings Per Share $0.07 -$2.26
Diluted Earnings Per Share $0.01 $0.07 -$2.26
COMMON SHARES
Basic Shares Outstanding 88.20M 83.05M
Diluted Shares Outstanding 129.4M 83.05M

Balance Sheet

Concept 2023 Q4 2023 2021
SHORT-TERM ASSETS
Cash & Short-Term Investments $35.60M $35.60M $64.36M
YoY Change -43.07% -43.07% 361.8%
Cash & Equivalents $35.60M
Short-Term Investments
Other Short-Term Assets $1.170M $6.179M $7.090M
YoY Change -49.2% -26.51% 153.85%
Inventory
Prepaid Expenses $5.009M
Receivables $28.07M $28.07M $18.22M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $69.85M $69.85M $89.68M
YoY Change -27.84% -27.84% 210.19%
LONG-TERM ASSETS
Property, Plant & Equipment $18.31M $32.62M $13.05M
YoY Change 16.21% 45.03% 48.58%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $6.502M $6.502M $3.356M
YoY Change 45.0% 45.0% 139.03%
Total Long-Term Assets $39.12M $39.12M $16.41M
YoY Change 45.02% 45.02% 61.04%
TOTAL ASSETS
Total Short-Term Assets $69.85M $69.85M $89.68M
Total Long-Term Assets $39.12M $39.12M $16.41M
Total Assets $109.0M $109.0M $106.1M
YoY Change -11.97% -11.97% 171.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.212M $2.212M $2.528M
YoY Change 31.28% 31.28% 422.31%
Accrued Expenses $18.10M $18.10M $5.578M
YoY Change 15.3% 15.3% -24.33%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change -100.0%
Total Short-Term Liabilities $20.31M $20.31M $8.106M
YoY Change 16.85% 16.85% -23.89%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $11.18M $11.18M $538.0K
YoY Change 277.86% 277.86% 25.12%
Total Long-Term Liabilities $11.18M $11.18M $538.0K
YoY Change 277.86% 277.86% -99.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $20.31M $20.31M $8.106M
Total Long-Term Liabilities $11.18M $11.18M $538.0K
Total Liabilities $31.49M $55.31M $50.79M
YoY Change 54.83% -5.9% -52.6%
SHAREHOLDERS EQUITY
Retained Earnings -$172.9M
YoY Change -3.32%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $53.67M $53.67M $55.30M
YoY Change
Total Liabilities & Shareholders Equity $109.0M $109.0M $106.1M
YoY Change -11.97% -11.97% 171.32%

Cashflow Statement

Concept 2023 Q4 2023 2021
OPERATING ACTIVITIES
Net Income $638.0K $6.025M -$158.3M
YoY Change 46.0% -178.72% -3998.47%
Depreciation, Depletion And Amortization $3.515M $9.987M $3.975M
YoY Change 107.99% 57.42% 73.51%
Cash From Operating Activities $6.586M $25.63M -$318.0K
YoY Change -12.43% 81.08% -119.1%
INVESTING ACTIVITIES
Capital Expenditures $2.295M $4.453M $8.014M
YoY Change 31.44% -43.85% 58.13%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$2.295M -$9.671M -$8.014M
YoY Change 31.44% 21.94% 58.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $17.32M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -579.0K -43.08M 58.85M
YoY Change -91.78% 441.31% 409.12%
NET CHANGE
Cash From Operating Activities 6.586M 25.63M -318.0K
Cash From Investing Activities -2.295M -9.671M -8.014M
Cash From Financing Activities -579.0K -43.08M 58.85M
Net Change In Cash 3.712M -26.94M 50.43M
YoY Change -392.98% 1380.27% 527.2%
FREE CASH FLOW
Cash From Operating Activities $6.586M $25.63M -$318.0K
Capital Expenditures $2.295M $4.453M $8.014M
Free Cash Flow $4.291M $21.18M -$8.332M
YoY Change -25.7% 240.26% 144.84%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001868912
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-40949
CY2023 dei Entity Registrant Name
EntityRegistrantName
ENFUSION, INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-1268462
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
125 South Clark Street
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 750
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Chicago
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60603
CY2023 dei City Area Code
CityAreaCode
312
CY2023 dei Local Phone Number
LocalPhoneNumber
253-9800
CY2023 dei Security12b Title
Security12bTitle
Class A common stock, par value $0.001 per share
CY2023 dei Trading Symbol
TradingSymbol
ENFN
CY2023 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
false
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
438200000
CY2023 dei Auditor Firm
AuditorFirmId
42
CY2023 dei Auditor Name
AuditorName
Ernst & Young LLP
CY2023 dei Auditor Location
AuditorLocation
Chicago, Illinois
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35604000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
62545000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
28069000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
25855000
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5009000
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
6105000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1170000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2303000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
69852000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
96808000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18314000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15759000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
14304000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6732000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6502000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4484000
CY2023Q4 us-gaap Assets
Assets
108972000
CY2022Q4 us-gaap Assets
Assets
123783000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2212000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1685000
CY2023Q4 enfn Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
13841000
CY2022Q4 enfn Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
11665000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4256000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4030000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
20309000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
17380000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11181000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2959000
CY2023Q4 us-gaap Liabilities
Liabilities
31490000
CY2022Q4 us-gaap Liabilities
Liabilities
20339000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
226877000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
244260000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-172932000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-178863000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-406000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-504000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
53666000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
65007000
CY2023Q4 us-gaap Minority Interest
MinorityInterest
23816000
CY2022Q4 us-gaap Minority Interest
MinorityInterest
38437000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
77482000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
103444000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
108972000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
123783000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
174535000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
150349000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
111700000
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
57641000
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
47100000
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
31845000
CY2023 us-gaap Gross Profit
GrossProfit
116894000
CY2022 us-gaap Gross Profit
GrossProfit
103249000
CY2021 us-gaap Gross Profit
GrossProfit
79855000
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
64635000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
68764000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
150614000
CY2023 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
20418000
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
29286000
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
51725000
CY2023 enfn Technology And Development Expense
TechnologyAndDevelopmentExpense
19893000
CY2022 enfn Technology And Development Expense
TechnologyAndDevelopmentExpense
17163000
CY2021 enfn Technology And Development Expense
TechnologyAndDevelopmentExpense
153400000
CY2023 us-gaap Operating Expenses
OperatingExpenses
104946000
CY2022 us-gaap Operating Expenses
OperatingExpenses
115213000
CY2021 us-gaap Operating Expenses
OperatingExpenses
355739000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
11948000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-11964000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-275884000
CY2023 enfn Payment To Related Party
PaymentToRelatedParty
1501000
CY2023 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1641000
CY2022 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
413000
CY2021 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-4594000
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-604000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-638000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1185000
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-464000
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-225000
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5779000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11484000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12189000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-281663000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2231000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1074000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
579000
CY2023 us-gaap Profit Loss
ProfitLoss
9253000
CY2022 us-gaap Profit Loss
ProfitLoss
-13263000
CY2021 us-gaap Profit Loss
ProfitLoss
-282242000
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3228000
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-5609000
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-123925000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
6025000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-7654000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-158317000
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.26
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.26
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
88202000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85393000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
83045000
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
129429000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
85393000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
83045000
CY2023 us-gaap Profit Loss
ProfitLoss
9253000
CY2022 us-gaap Profit Loss
ProfitLoss
-13263000
CY2021 us-gaap Profit Loss
ProfitLoss
-282242000
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
143000
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-327000
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-90000
CY2023 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
9396000
CY2022 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-13590000
CY2021 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-282332000
CY2023 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
3273000
CY2022 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-5757000
CY2021 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-123902000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6123000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7833000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-158430000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-233559000
enfn Net Income Loss Excluding Preferred Units
NetIncomeLossExcludingPreferredUnits
6078000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-145000
enfn Distribution Made To Partners
DistributionMadeToPartners
1476000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-229102000
CY2021Q4 enfn Reorganization Transaction Adjustments
ReorganizationTransactionAdjustments
-170522000
CY2021Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
259710000
CY2021Q4 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
87846000
CY2021Q4 enfn Net Income Loss Excluding Preferred Units
NetIncomeLossExcludingPreferredUnits
-295134000
CY2021Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
279236000
CY2021Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
55000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
97441000
CY2022 us-gaap Profit Loss
ProfitLoss
-13263000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
25593000
CY2022 enfn Tax Withholdings Related To Net Share Settlements Of Stock Based Compensation Awards
TaxWithholdingsRelatedToNetShareSettlementsOfStockBasedCompensationAwards
7959000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-327000
CY2022 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
1959000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
103444000
CY2023 us-gaap Profit Loss
ProfitLoss
9253000
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8224000
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
17322000
CY2023 enfn Tax Withholdings Related To Net Share Settlements Of Stock Based Compensation Awards
TaxWithholdingsRelatedToNetShareSettlementsOfStockBasedCompensationAwards
60447000
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
143000
CY2023 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-308000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
77482000
CY2023 us-gaap Profit Loss
ProfitLoss
9253000
CY2022 us-gaap Profit Loss
ProfitLoss
-13263000
CY2021 us-gaap Profit Loss
ProfitLoss
-282242000
CY2023 enfn Non Cash Change In Operating Lease
NonCashChangeInOperatingLease
6882000
CY2022 enfn Non Cash Change In Operating Lease
NonCashChangeInOperatingLease
5351000
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9987000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6344000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3975000
CY2023 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
1319000
CY2022 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
1399000
CY2021 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
1450000
CY2023 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
92000
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
26000
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
222000
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-78000
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1215000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
7458000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
24993000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
289803000
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3679000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9031000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7493000
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1749000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1767000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6477000
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
365000
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-843000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2044000
CY2023 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-729000
CY2022 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
7087000
CY2021 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-2081000
CY2023 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
2359000
CY2022 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1029000
CY2021 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-734000
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-6002000
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-5111000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
25634000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
14156000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-318000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4453000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3985000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6096000
CY2023 us-gaap Capitalized Computer Software Period Increase Decrease
CapitalizedComputerSoftwarePeriodIncreaseDecrease
-5218000
CY2022 us-gaap Capitalized Computer Software Period Increase Decrease
CapitalizedComputerSoftwarePeriodIncreaseDecrease
-3946000
CY2021 us-gaap Capitalized Computer Software Period Increase Decrease
CapitalizedComputerSoftwarePeriodIncreaseDecrease
-1918000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9671000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7931000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8014000
CY2023 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1151000
CY2023 enfn Receipt Of Tax Refund
ReceiptOfTaxRefund
1501000
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
17322000
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
260545000
CY2023 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
60447000
CY2022 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
7959000
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
10567000
CY2021 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
100000000
CY2021 us-gaap Distribution Made To Limited Liability Company Llc Member Cash Distributions Paid
DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsPaid
3283000
CY2021 enfn Payment For Purchase Of Common Units
PaymentForPurchaseOfCommonUnits
87846000
CY2023 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-308000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-43083000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-7959000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
58849000
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
179000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-86000
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-90000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-26941000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1820000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
50427000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
62545000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
64365000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13938000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35604000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
62545000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
64365000
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1843000
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1582000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
407000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
4813000
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
13893000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
9514000
CY2023 us-gaap Employee Benefits And Share Based Compensation Noncash
EmployeeBenefitsAndShareBasedCompensationNoncash
766000
CY2022 us-gaap Employee Benefits And Share Based Compensation Noncash
EmployeeBenefitsAndShareBasedCompensationNoncash
600000
CY2023 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
608000
CY2021 enfn Effect Of Reorganization Transactions
EffectOfReorganizationTransactions
58223000
CY2021 enfn Stock Issue Costs Included In Accrued Expenses And Other Liabilities
StockIssueCostsIncludedInAccruedExpensesAndOtherLiabilities
835000
CY2022 enfn Noncash Other
NoncashOther
1959000
CY2023 us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Note 1   Organization and Description of Business</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Enfusion is a leading provider of cloud-based order and execution management, portfolio management and risk systems. Enfusion’s clients include large global hedge fund managers, institutional asset managers, family offices and other institutional investors. Enfusion provides its clients with innovative real-time performance, risk calculations, and accounting capabilities for some of the most sophisticated financial products. The Company is headquartered in Chicago, Illinois and has offices in New York City, London, Dublin, Hong Kong, Singapore, Mumbai, Bengaluru, and Sydney. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Enfusion, Inc. was incorporated in Delaware on June 11, 2021 for the purpose of facilitating an initial public offering, which was completed on October 25, 2021, and other related transactions in order to carry on the business of Enfusion Ltd. LLC. Enfusion, Inc. is a holding company and, through its control over the managing member of Enfusion Ltd. LLC, operates and controls Enfusion Ltd. LLC. Enfusion, Inc.’s principal asset consists of Common Units.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Enfusion, Inc. has three wholly-owned subsidiaries: Enfusion US 1, Inc., Enfusion US 2, Inc., and Enfusion US 3, Inc.; as well as a controlling financial interest in Enfusion Ltd. LLC and its majority-owned subsidiary, Enfusion Softech India Private Limited, as well as the wholly-owned subsidiaries of Enfusion Ltd. LLC: Enfusion Systems UK Ltd, Enfusion HK Limited, Enfusion Software Limited, Enfusion (Singapore) Pte. Ltd., Enfusion do Brasil Tecnologia da Informacão Ltd, Enfusion (Australia) Pty. Ltd., Enfusion (Shanghai) Co., and Enfusion Tech Ltd. Enfusion, Inc., through its control over the managing member of Enfusion Ltd. LLC, manages and operates Enfusion Ltd. LLC’s business and controls its strategic decisions and day-to-day operations. As such, Enfusion, Inc. consolidates the financial results of Enfusion Ltd. LLC, and a portion of Enfusion, Inc.’s net income (loss) is allocated to non-controlling interests to reflect the entitlement to a portion of Enfusion Ltd. LLC’s net income (loss) by the other common unitholders of Enfusion, Ltd. LLC. As of December 31, 2023, Enfusion, Inc. owned 69.3% of Enfusion Ltd. LLC.</p>
CY2023 enfn Number Of Subsidiaries
NumberOfSubsidiaries
3
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. We base our estimates on historical experience and various other assumptions believed to be reasonable. These estimates and assumptions include, but are not limited to, judgments affecting the measurement of the payable to related parties pursuant to the Tax Receivable Agreement, amortization periods, certain assumptions used in the valuation of stock-based compensation, assessment of the allowance for credit losses, and accounting for income taxes and assessment of valuation allowances. Actual results could differ from those estimates. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company’s results can also be affected by economic, political, legislative, regulatory, and legal actions, including but not limited to health epidemics and pandemics and the resulting economic impact. Economic conditions, such as recessionary trends, inflation, interest and monetary exchange rates, and government fiscal policies can have a significant effect on operations. While the Company maintains reserves for anticipated liabilities and carries various levels of insurance, the Company could be affected by civil, criminal, regulatory, or administrative actions, claims, or proceedings.</p>
CY2023 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Reclassifications</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Certain amounts in prior periods have been reclassified to conform with the current period presentation.</p>
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
30000000.0
CY2022Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
50000000.0
CY2023 enfn Period For Payment Of Fees After Invoice Date
PeriodForPaymentOfFeesAfterInvoiceDate
P30D
CY2023Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
2400000
CY2022Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
2000000.0
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
1700000
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
1500000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
791000
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1158000
CY2022 enfn Accounts Receivable Allowance For Credit Loss Writeoff Net Of Recoveries
AccountsReceivableAllowanceForCreditLossWriteoffNetOfRecoveries
-724000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1225000
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
705000
CY2023 enfn Accounts Receivable Allowance For Credit Loss Writeoff Net Of Recoveries
AccountsReceivableAllowanceForCreditLossWriteoffNetOfRecoveries
-987000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1092000
CY2023 us-gaap Property Plant And Equipment Preproduction Design And Development Costs
PropertyPlantAndEquipmentPreproductionDesignAndDevelopmentCosts
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Software Development Costs</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company capitalizes certain qualifying costs, including stock-based compensation expense, incurred in the development of and major enhancements to the Company's cloud-based software as a service (“SaaS”) platform and related software products. Capitalized software development costs related to the Company's platform are amortized on a straight-line basis over the developed software's estimated useful life of three years, and the related amortization expense is recorded in cost of revenues within our consolidated statements of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Costs incurred in the preliminary stages of development are expensed as incurred. Costs incurred for post-implementation activities, training, maintenance, and minor upgrades and enhancements without adding additional functionality are expensed as incurred within technology and development expense in our consolidated statements of operations.</p>
CY2021 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2022 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2023 enfn Period For Payment Of Fees After Invoice Date
PeriodForPaymentOfFeesAfterInvoiceDate
P30D
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
29100000
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
18227000
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
8845000
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1986000
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
64000
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
29122000
CY2023Q4 enfn Deferred Commissions
DeferredCommissions
3500000
CY2022Q4 enfn Deferred Commissions
DeferredCommissions
2800000
CY2023 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
1400000
CY2022 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
845000
CY2021 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
228000
CY2023 us-gaap Advertising Expense
AdvertisingExpense
1500000
CY2022 us-gaap Advertising Expense
AdvertisingExpense
1500000
CY2021 us-gaap Advertising Expense
AdvertisingExpense
1200000
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Concentration of Risk</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Deposits with Financial Institutions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company has concentrated its credit risk for cash by maintaining deposits in several financial institutions, which may at times exceed amounts covered by insurance provided by the Federal Deposit Insurance Corporation. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk related to cash.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Accounts Receivable</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2023, the Company had one individual client that represented 10% or more of accounts receivables. For the years ended December 31, 2023, 2022, and 2021, no individual client represented more than 10% of the Company’s total revenues.</p>
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
35031000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
29166000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
16717000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
13407000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18314000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15759000
CY2023 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
6400000
CY2022 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
4500000
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5100000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3300000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2400000
CY2023 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
3400000
CY2022 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
2200000
CY2021 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
1300000
CY2023Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
10058000
CY2022Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
10268000
CY2023Q4 enfn Accrued Expenses Current
AccruedExpensesCurrent
1385000
CY2022Q4 enfn Accrued Expenses Current
AccruedExpensesCurrent
1112000
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
2398000
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
285000
CY2023Q4 enfn Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
13841000
CY2022Q4 enfn Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
11665000
CY2023Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
6400000
CY2022Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
7800000
CY2023 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2023 us-gaap Lessee Operating Lease Existence Of Option To Terminate
LesseeOperatingLeaseExistenceOfOptionToTerminate
true
CY2022 enfn Number Of Finance Leases
NumberOfFinanceLeases
0
CY2023 enfn Number Of Finance Leases
NumberOfFinanceLeases
0
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
5197000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
4198000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
3229000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
3253000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1671000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
654000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
18202000
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2765000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
15437000
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
6882000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
5053000
CY2023 us-gaap Variable Lease Cost
VariableLeaseCost
835000
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
828000
CY2023 us-gaap Short Term Lease Cost
ShortTermLeaseCost
114000
CY2023 us-gaap Lease Cost
LeaseCost
7831000
CY2022 us-gaap Lease Cost
LeaseCost
5881000
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y9M18D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y10M2D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0780
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0443
CY2021 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
3900000
CY2021 enfn Service Agreements Expense
ServiceAgreementsExpense
1100000
CY2023Q1 enfn Common Units Surrendered
CommonUnitsSurrendered
1000000
CY2023Q1 enfn Common Units Surrendered
CommonUnitsSurrendered
1000000
CY2023Q3 enfn Common Units Surrendered
CommonUnitsSurrendered
1000000
CY2023Q3 enfn Common Units Surrendered
CommonUnitsSurrendered
1000000
CY2023Q1 enfn Increase In Common Units
IncreaseInCommonUnits
1000000
CY2023Q1 enfn Increase In Common Units
IncreaseInCommonUnits
1000000
CY2023Q3 enfn Increase In Common Units
IncreaseInCommonUnits
1000000
CY2023Q3 enfn Increase In Common Units
IncreaseInCommonUnits
1000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7458000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
24993000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
289803000
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7500000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
25000000.0
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
289800000
CY2023 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
766000
CY2022 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
600000
CY2021 enfn Share Based Compensation Arrangements By Share Based Payment Award Shares Granted Capitalizable Activities
ShareBasedCompensationArrangementsByShareBasedPaymentAwardSharesGrantedCapitalizableActivities
0
CY2023Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
19700000
CY2023 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y
CY2023 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.50
CY2023 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.03
CY2023 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
1000000.0
CY2022 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
584000
CY2021 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
452000
CY2023 us-gaap Profit Loss
ProfitLoss
9253000
CY2022 us-gaap Profit Loss
ProfitLoss
-13263000
CY2021 us-gaap Profit Loss
ProfitLoss
-282242000
CY2021 enfn Net Income Loss Attributable To Parent Prior To Ipo
NetIncomeLossAttributableToParentPriorToIpo
12892000
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3228000
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-5609000
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-123925000
CY2023 enfn Net Income Loss Attributable To Parent Subsequent To Ipo
NetIncomeLossAttributableToParentSubsequentToIpo
6025000
CY2022 enfn Net Income Loss Attributable To Parent Subsequent To Ipo
NetIncomeLossAttributableToParentSubsequentToIpo
-7654000
CY2021 enfn Net Income Loss Attributable To Parent Subsequent To Ipo
NetIncomeLossAttributableToParentSubsequentToIpo
-171209000
CY2023 enfn Net Income Loss Attributable To Parent Subsequent To Ipo
NetIncomeLossAttributableToParentSubsequentToIpo
6025000
CY2022 enfn Net Income Loss Attributable To Parent Subsequent To Ipo
NetIncomeLossAttributableToParentSubsequentToIpo
-7654000
CY2021 enfn Net Income Loss Attributable To Parent Subsequent To Ipo
NetIncomeLossAttributableToParentSubsequentToIpo
-171209000
CY2023 enfn Adjustments To Net Income Loss Attributable To Common Stockholders
AdjustmentsToNetIncomeLossAttributableToCommonStockholders
306000
CY2022 enfn Adjustments To Net Income Loss Attributable To Common Stockholders
AdjustmentsToNetIncomeLossAttributableToCommonStockholders
-954000
CY2021 enfn Adjustments To Net Income Loss Attributable To Common Stockholders
AdjustmentsToNetIncomeLossAttributableToCommonStockholders
-16580000
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
6331000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8608000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-187789000
CY2023 us-gaap Dilutive Securities
DilutiveSecurities
2922000
CY2023 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
9253000
CY2022 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-8608000
CY2021 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-187789000
CY2023 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
80828000
CY2023 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
2190000
CY2022 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
67057000
CY2021 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
65583000
CY2023 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
7374000
CY2022 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
18336000
CY2021 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
17462000
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
88202000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85393000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
83045000
CY2023 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
41227000
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
129429000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
85393000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
83045000
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.26
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.26
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1132000
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
46242000
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
52102000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
5503000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-16201000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-279990000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
5981000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
4012000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-1673000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11484000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12189000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-281663000
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-5000
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
53000
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
1347000
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
228000
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
2238000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1347000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
228000
CY2023 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-7000
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-273000
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
351000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-7000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-273000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
351000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2231000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1074000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
579000
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.389
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.031
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.043
CY2023 us-gaap Effective Income Tax Rate Reconciliation Minority Interest Income Expense
EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
0.073
CY2022 us-gaap Effective Income Tax Rate Reconciliation Minority Interest Income Expense
EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
0.089
CY2021 us-gaap Effective Income Tax Rate Reconciliation Minority Interest Income Expense
EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
0.092
CY2023 enfn Effective Income Tax Rate Reconciliation Foreign Branch Taxes Percent
EffectiveIncomeTaxRateReconciliationForeignBranchTaxesPercent
0.109
CY2022 enfn Effective Income Tax Rate Reconciliation Foreign Branch Taxes Percent
EffectiveIncomeTaxRateReconciliationForeignBranchTaxesPercent
-0.082
CY2021 enfn Effective Income Tax Rate Reconciliation Foreign Branch Taxes Percent
EffectiveIncomeTaxRateReconciliationForeignBranchTaxesPercent
-0.003
CY2023 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
1.135
CY2022 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.106
CY2021 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.025
CY2023 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.003
CY2022 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.005
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-1.688
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.506
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.145
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.019
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.592
CY2023 enfn Effective Income Tax Rate Reconciliation Return To Provision
EffectiveIncomeTaxRateReconciliationReturnToProvision
0.065
CY2022 enfn Effective Income Tax Rate Reconciliation Return To Provision
EffectiveIncomeTaxRateReconciliationReturnToProvision
0.040
CY2021 enfn Effective Income Tax Rate Reconciliation Return To Provision
EffectiveIncomeTaxRateReconciliationReturnToProvision
0.001
CY2023 enfn Effective Income Tax Rate Reconciliation Unrecognized Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitPercent
0.021
CY2021 enfn Effective Income Tax Rate Reconciliation Rate Effect From Pass Through Entity Percent
EffectiveIncomeTaxRateReconciliationRateEffectFromPassThroughEntityPercent
0.009
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.004
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.011
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.194
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.088
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.002
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.194
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.088
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.002
CY2023 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
4500000
CY2022 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
-400000
CY2021 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
-12100000
CY2023 enfn Income Tax Expense Benefit Attributable To Noncontrolling Interest
IncomeTaxExpenseBenefitAttributableToNoncontrollingInterest
-800000
CY2022 enfn Income Tax Expense Benefit Attributable To Noncontrolling Interest
IncomeTaxExpenseBenefitAttributableToNoncontrollingInterest
1100000
CY2021 enfn Income Tax Expense Benefit Attributable To Noncontrolling Interest
IncomeTaxExpenseBenefitAttributableToNoncontrollingInterest
25900000
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
13000000.0
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
1300000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
2500000
CY2023Q4 enfn Net Deferred Tax Benefit
NetDeferredTaxBenefit
-19400000
CY2022Q4 enfn Net Deferred Tax Benefit
NetDeferredTaxBenefit
-6200000
CY2021Q4 enfn Net Deferred Tax Benefit
NetDeferredTaxBenefit
40800000
CY2023 enfn Income Tax Reconciliation Foreign Branch Taxes
IncomeTaxReconciliationForeignBranchTaxes
1300000
CY2022 enfn Income Tax Reconciliation Foreign Branch Taxes
IncomeTaxReconciliationForeignBranchTaxes
1000000.0
CY2021 enfn Income Tax Reconciliation Foreign Branch Taxes
IncomeTaxReconciliationForeignBranchTaxes
600000
CY2023Q4 enfn Income Tax Expense Benefit Relating To Income Tax Returns
IncomeTaxExpenseBenefitRelatingToIncomeTaxReturns
800000
CY2022Q4 enfn Income Tax Expense Benefit Relating To Income Tax Returns
IncomeTaxExpenseBenefitRelatingToIncomeTaxReturns
-500000
CY2021Q4 enfn Income Tax Expense Benefit Relating To Income Tax Returns
IncomeTaxExpenseBenefitRelatingToIncomeTaxReturns
-200000
CY2023Q4 enfn Increase Or Decrease In Deferred Tax Assets
IncreaseOrDecreaseInDeferredTaxAssets
-200000
CY2022Q4 enfn Increase Or Decrease In Deferred Tax Assets
IncreaseOrDecreaseInDeferredTaxAssets
-7200000
CY2023Q4 us-gaap Deferred Tax Assets Investments
DeferredTaxAssetsInvestments
126504000
CY2022Q4 us-gaap Deferred Tax Assets Investments
DeferredTaxAssetsInvestments
86117000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1542000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
37912000
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
11410000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
9358000
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
851000
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
794000
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
140307000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
134181000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
140307000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
133689000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
492000
CY2023Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
70000
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
77000
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
70000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
77000
CY2023Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
70000
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
415000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
124526000
CY2022 enfn Valuation Allowance Deferred Tax Asset Increase Decrease Charged To Income Tax Expense
ValuationAllowanceDeferredTaxAssetIncreaseDecreaseChargedToIncomeTaxExpense
-6163000
CY2022 enfn Valuation Allowance Deferred Tax Asset Increase Decrease Charged To Stockholders Equity
ValuationAllowanceDeferredTaxAssetIncreaseDecreaseChargedToStockholdersEquity
15326000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
133689000
CY2023 enfn Valuation Allowance Deferred Tax Asset Increase Decrease Charged To Income Tax Expense
ValuationAllowanceDeferredTaxAssetIncreaseDecreaseChargedToIncomeTaxExpense
-19381000
CY2023 enfn Valuation Allowance Deferred Tax Asset Increase Decrease Charged To Stockholders Equity
ValuationAllowanceDeferredTaxAssetIncreaseDecreaseChargedToStockholdersEquity
25999000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
140307000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
119000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
119000
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
0
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
30000
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
238000
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
0
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
89000
CY2023 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
41000
CY2022 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
0
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
316000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
119000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
119000
CY2023Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
128000
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
65000
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
65000
CY2023Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
128000
CY2023 enfn Percentage Of Entity S Share Of Tax Benefits Under Tax Receivable Agreement
PercentageOfEntitySShareOfTaxBenefitsUnderTaxReceivableAgreement
0.85
CY2023 enfn Percentage Of Other S Share Of Tax Benefits Under Tax Receivable Agreement
PercentageOfOtherSShareOfTaxBenefitsUnderTaxReceivableAgreement
0.15
CY2023Q4 enfn Significant Change In Tax Receivable Agreement If Determined Reasonably Possible Amount Of Unrecorded Tax Liability
SignificantChangeInTaxReceivableAgreementIfDeterminedReasonablyPossibleAmountOfUnrecordedTaxLiability
96500000
CY2022Q4 enfn Significant Change In Tax Receivable Agreement If Determined Reasonably Possible Amount Of Unrecorded Tax Liability
SignificantChangeInTaxReceivableAgreementIfDeterminedReasonablyPossibleAmountOfUnrecordedTaxLiability
83200000

Files In Submission

Name View Source Status
0001558370-24-002987-index-headers.html Edgar Link pending
0001558370-24-002987-index.html Edgar Link pending
0001558370-24-002987.txt Edgar Link pending
0001558370-24-002987-xbrl.zip Edgar Link pending
enfn-20231231.xsd Edgar Link pending
enfn-20231231x10k.htm Edgar Link pending
enfn-20231231x10k001.jpg Edgar Link pending
enfn-20231231x10k002.jpg Edgar Link pending
enfn-20231231xex10d10.htm Edgar Link pending
enfn-20231231xex10d10001.jpg Edgar Link pending
enfn-20231231xex10d11.htm Edgar Link pending
enfn-20231231xex10d11001.jpg Edgar Link pending
enfn-20231231xex10d12.htm Edgar Link pending
enfn-20231231xex10d12001.jpg Edgar Link pending
enfn-20231231xex10d6.htm Edgar Link pending
enfn-20231231xex10d7.htm Edgar Link pending
enfn-20231231xex10d7001.jpg Edgar Link pending
enfn-20231231xex10d8.htm Edgar Link pending
enfn-20231231xex10d8001.jpg Edgar Link pending
enfn-20231231xex21d1.htm Edgar Link pending
enfn-20231231xex23d1.htm Edgar Link pending
enfn-20231231xex31d1.htm Edgar Link pending
enfn-20231231xex31d2.htm Edgar Link pending
enfn-20231231xex32d1.htm Edgar Link pending
enfn-20231231xex32d2.htm Edgar Link pending
enfn-20231231xex97.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
enfn-20231231_cal.xml Edgar Link unprocessable
enfn-20231231_def.xml Edgar Link unprocessable
enfn-20231231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
enfn-20231231x10k_htm.xml Edgar Link completed
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
enfn-20231231_lab.xml Edgar Link unprocessable